Cencora Inc. ($COR) Stock Forecast: Down 6.4% Today

What is Cencora Inc.?

Cencora (COR) is a company that has shown strong performance in the pharmaceutical sector, benefiting notably from specialty and GLP-1 demand. With a market capitalization of $55.89 billion, the stock has outperformed the market in recent years.

Why is Cencora Inc. going down?

COR stock is down 6.4% on Aug 6, 2025 13:41

• The bearish movement in COR stock today may be linked to the market's reaction to the company's Q3 earnings, despite exceeding earnings and revenue expectations. Here's a breakdown of the situation:
• The market could have anticipated more robust results given COR's consistent outperformance, leading to a sell-off.
• Worries about international challenges impacting Q3 figures might have unsettled investors, overshadowing the positive earnings beats.
• Investors expecting a significant earnings beat based on Wall Street projections might have felt let down, resulting in a decline in the stock's value.
• While hopes were high for COR's earnings growth, the market's response today indicates that even surpassing estimates does not always guarantee a positive reaction from investors.

COR Price Chart

COR Technical Analysis

COR News

Cencora ( COR ) Q3 Earnings and Revenues Surpass Estimates

Cencora (COR) delivered earnings and revenue surprises of +5.82% and +0.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2672374/cencora-cor-q3-earnings-and-revenues-surpass-estimates

Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results?

COR benefits from strong specialty and GLP-1 demand, but Q3 results may face pressure from international weakness.

https://www.zacks.com/stock/news/2663057/can-specialty-and-glp-1-momentum-support-cencoras-q3-results

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Cencora ( NYSE:COR )

Cencora COR has outperformed the market over the past 10 years by 7.98% on an annualized basis producing an average annual return of 19.65%. Currently, Cencora has a market capitalization of $55.89 billion.

https://www.benzinga.com/insights/news/25/08/46829063/1000-invested-in-this-stock-10-years-ago-would-be-worth-this-much-today

Gear Up for Cencora ( COR ) Q3 Earnings: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

https://www.zacks.com/stock/news/2648843/gear-up-for-cencora-cor-q3-earnings-wall-street-estimates-for-key-metrics

Cencora ( COR ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

https://www.zacks.com/stock/news/2638782/cencora-cor-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release

Trending Today

Blink Charging Co. ($BLNK) Stock Forecast: Down 5.4% Today

Rockwell Automation Inc. ($ROK) Stock Forecast: Down 9.3% Today

MercadoLibre Inc. ($MELI) Stock Forecast: Down 3.1% Today

Amgen Inc. ($AMGN) Stock Forecast: Down 5.2% Today

Walmart Inc. ($WMT) Stock Forecast: Up 1.8% Today

Unity Software ($U) Stock Forecast: Down 5.3% Today

StoneCo Ltd. ($STNE) Stock Forecast: Up 5.1% Today

Kornit Digital Ltd. ($KRNT) Stock Forecast: Down 25.3% Today

Chegg Inc. ($CHGG) Stock Forecast: Down 13.9% Today

Aurora Cannabis Inc. ($ACB) Stock Forecast: Down 5.6% Today

Cencora Inc. Price History

06.07.2025 - COR Stock was down 6.4%

• The bearish movement in COR stock today may be linked to the market's reaction to the company's Q3 earnings, despite exceeding earnings and revenue expectations. Here's a breakdown of the situation:
• The market could have anticipated more robust results given COR's consistent outperformance, leading to a sell-off.
• Worries about international challenges impacting Q3 figures might have unsettled investors, overshadowing the positive earnings beats.
• Investors expecting a significant earnings beat based on Wall Street projections might have felt let down, resulting in a decline in the stock's value.
• While hopes were high for COR's earnings growth, the market's response today indicates that even surpassing estimates does not always guarantee a positive reaction from investors.

06.10.2024 - COR Stock was up 5.1%

• In the fourth quarter of 2024, COR exceeded sales expectations, seeing a significant revenue increase in both U.S. and International Healthcare Solutions segments.
• Despite a year-over-year decline in margins, COR's overall Q4 performance was impressive, resulting in an increased dividend and positive market sentiment.
• Analysts were optimistic about COR's earnings and revenue estimates, suggesting potential for ongoing stock growth.
• The market responded positively to COR's better-than-expected Q4 earnings and revenue, propelling the bullish movement in the stock price.

03.00.2025 - COR Stock was up 3.4%

• Market expectations point towards a potential increase in COR stock, reflecting optimistic investor sentiment.
• COR has outperformed the market by 4.82% annually over the last decade, highlighting its robust historical performance.
• Today's positive uptick in COR may be linked to the favorable outlook in the options market and its consistent market outperformance.

15.09.2024 - COR Stock was up 2.3%

• COR experienced a strong bullish movement recently, possibly due to investor optimism and confidence in the company's financial performance.
• Expectations of COR surpassing earnings estimates in the near future may have influenced the positive market sentiment.
• The consistent outperformance of COR compared to the market could have attracted more investors, boosting the stock price.
• In summary, COR's solid historical performance, anticipated positive earnings, and market outperformance likely drove the recent bullish movement in the stock.

08.04.2025 - COR Stock was down 4.2%

• Despite surpassing Q2 earnings and revenue estimates, COR witnessed a bearish movement in the market.
• Concerns about revenue sustainability and competition in the pharmaceutical sector may have contributed to the market's negative reaction.
• Investor caution regarding the company's growth sustainability could result in profit-taking and a bearish stock price trend.
• Broader economic factors and sector-specific challenges in the pharmaceutical industry might also influence the market movement.

08.04.2025 - COR Stock was down 5.2%

• Despite surpassing Q2 earnings and revenue expectations, COR observed a decline in its stock price today.
• The high demand for weight loss drugs and specialty products might not have sustained the stock's elevated value, resulting in profit-taking by traders.
• The market's response could be due to concerns regarding future growth prospects or uncertainties about the company's trajectory.
• Investors may have anticipated stronger results or guidance from COR, triggering a stock sell-off despite its recent accomplishments in the healthcare solutions industry.

15.09.2024 - COR Stock was up 5.7%

• Cencora's stock price surged today as investors continue to be impressed by its consistent outperformance compared to the market over the past 5 years.
• The significant growth of $1000 invested in Cencora 5 years ago to $2,700 today likely attracted more investors to the stock, driving up demand.
• The market capitalization of $43.54 billion indicates strong investor confidence in Cencora's future growth prospects, further fueling today's bullish movement.
• Overall, Cencora's impressive track record and positive market sentiment seem to have contributed to today's strong bullish performance.

05.01.2025 - COR Stock was down 0.3%

• The bearish movement in COR stock today could be attributed to profit-taking by investors despite the company surpassing Q1 earnings and revenue estimates.
• The strong performance in the U.S. Healthcare Solutions segment might have been already priced in, leading to a sell-off.
• The stiff competition could be causing concerns among investors, leading to the bearish trend.
• The stock's historical outperformance and market capitalization may have set high expectations, and any deviation from this trajectory could trigger a negative market reaction.

07.04.2025 - COR Stock was up 5.7%

• COR outperformed Q2 earnings and revenue expectations, signaling robust financial results.
• The U.S. Healthcare Solutions segment's favorable outlook is anticipated to be a key driver of COR's success.
• Analysts hold a positive view on COR's crucial metrics for the quarter, indicating a favorable path for the company.
• Investors reacted favorably to the strong performance and growth potential of COR, leading to the uptrend in the stock price.

27.05.2024 - COR Stock was down 5.1%

• The recent decline in COR stock may be due to:
• Competition in the healthcare solutions sector impacting the company's growth outlook.
• Investor doubts about the company's competitive position despite its potential.
• Changes in market sentiment, potentially influenced by profit-taking or broader market conditions, contributing to the stock's downward trend.

04.03.2025 - COR Stock was down 0.7%

• Despite being considered a safe bet during market volatility, COR faced a strong bearish movement today.
• The comparison with other medical stocks like Intensity Therapeutics Inc. may have highlighted weaknesses in COR's performance, contributing to the bearish trend.
• The overall market volatility, potentially influenced by external factors, could have also played a role in the bearish movement of COR today.

31.06.2025 - COR Stock was down 2.4%

• The decline in COR's stock today could be due to profit-taking by investors who were possibly anticipating a positive earnings outcome.
• Comparisons with McKesson (MCK) in the medical sector may have impacted investor sentiment, resulting in a sell-off of COR as it might have shown lower performance compared to its sector so far this year.
• Investors might be reassessing their holdings in COR based on its performance relative to McKesson, potentially influencing the downward trend in the stock.